Jul 19, 2010
This episode is primarily relevant to consumers.
In this episode, R. Trent Codd, III, Ed.S., interviews Anne Marie Albano, PhD about Child Anxiety Disorders. In this episode they discuss:
ANNE MARIE ALBANO, PhD BIOGRAPHY
Dr. Anne Marie Albano is associate professor of clinical psychology in psychiatry within the Division of Child and Adolescent Psychiatry at the Columbia University College of Physicians and Surgeons, and Director of the Columbia University Clinic for Anxiety and Related Disorders. Dr. Albano received her Ph.D. in clinical psychology from the University of Mississippi and completed a postdoctoral fellowship at the Phobia and Anxiety Disorders Clinic of the Center for Stress and Anxiety Disorders at SUNY-Albany, under the mentorship of David H. Barlow, Ph.D. She has held past positions as the Assistant Director of the SUNY Phobia Clinic, Assistant Professor of Psychology at the University of Louisville, and the Recanati Family Assistant Professor of Psychiatry at the New York University School of Medicine.
Among her professional activities, Dr. Albano is past president of the Society for Clinical Child and Adolescent Psychology of the American Psychological Association and past president of the Association for Behavioral and Cognitive Therapies. She is Associate Editor of the Journal of Consulting and Clinical Psychology and a past Editor of the journal Cognitive and Behavioral Practice. Dr. Albano is a Founding Fellow of the Academy of Cognitive Therapy and a Beck Institute Scholar. She is board certified in Clinical Child and Adolescent Psychology.
Dr. Albano devotes her career to the study of anxiety and mood disorders in children, adolescents, and young adults. She has been a principal investigator on two of the largest clinical studies funded by the National Institutes of Mental Health, examining treatments for children and adolescents with anxiety and depression. In the Child/Adolescent Anxiety Multimodal Treatment Study (CAMS), 488 children ages 7 to 17 years with separation anxiety, social anxiety, and generalized anxiety disorders were treated with either cognitive behavioral therapy, medication, their combination, or pill placebo. Results indicated that all three active treatments were superior to pill placebo, with the combination treatment having the greatest advantage. These results tell us that anxiety in children and adolescents is highly treatable and that children do not need to suffer with these disorders. Dr. Albano is also a member of the Treatments for Adolescents with Depression Study (TADS) Team, having served as a contributor to the TADS Cognitive Behavioral Therapy manual and also as a principal investigator for this monumental research study. The TADS results found that for adolescents ages 12 to 17, the combination of cognitive behavioral therapy and medication results the greatest response rate in recovery from moderate to severe depression, followed by medication alone. Cognitive behavioral therapy alone takes several weeks longer to reach an effect, suggesting that use of CBT alone in milder cases is indicated. Overall, Dr. Albano's clinical and research careers have centered on developing and disseminating effective treatments for anxiety and depression in children, adolescents, and young adults.